Renal cell carcinoma classification: Difference between revisions

Jump to navigation Jump to search
Line 14: Line 14:
| bgcolor="#ececec"|'''Papillary''' || 12|| MET <br> TFE3|| 13 %<br> < 1 %
| bgcolor="#ececec"|'''Papillary''' || 12|| MET <br> TFE3|| 13 %<br> < 1 %
|-
|-
| bgcolor="#ececec"|'''Chromophobe''' || 4 %
| bgcolor="#ececec"|'''Chromophobe''' || 4 ||  ||
|-
|-
| bgcolor="#ececec"|'''Oncocytoma''' || 4 %
| bgcolor="#ececec"|'''Oncocytoma''' || 4 ||  ||
|-
|-
|bgcolor="#ececec"|'''Collecting Duct''' || < 1 %
|bgcolor="#ececec"|'''Collecting Duct''' || < 1 ||  ||
|-
|-
|bgcolor="#ececec"|'''Unclassified''' || 3 - 5 %
|bgcolor="#ececec"|'''Unclassified''' || 3 - 5 ||  ||
|}
|}
<sup><center>Adapted from Cohen HT, McGovern FJ. Renal-cell carcinoma.''N Engl J Med''. 2005; 353:2477-90</center></sup>
<sup><center>Adapted from Cohen HT, McGovern FJ. Renal-cell carcinoma.''N Engl J Med''. 2005; 353:2477-90</center></sup>

Revision as of 16:10, 27 December 2013

Renal cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Renal cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Renal cell carcinoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Renal cell carcinoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Renal cell carcinoma classification

CDC on Renal cell carcinoma classification

Renal cell carcinoma classification in the news

Blogs on Renal cell carcinoma classification

Directions to Hospitals Treating Renal cell carcinoma

Risk calculators and risk factors for Renal cell carcinoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

The following tables classify renal cell carcinoma according to histologic appearance and differentiates sporadic from hereditary forms of renal cell carcinoma.

Sporadic Forms of Renal Cell Carcinoma[1]
Histologic Appearance Incidence Gene Frequency
Conventional 75 VHL 60 %
Papillary 12 MET
TFE3
13 %
< 1 %
Chromophobe 4
Oncocytoma 4
Collecting Duct < 1
Unclassified 3 - 5
Adapted from Cohen HT, McGovern FJ. Renal-cell carcinoma.N Engl J Med. 2005; 353:2477-90


Hereditary Forms of Renal Cell Carcinoma[1]
Syndrome Associated Gene Common Histological Appearance
VHL Disease VHL Conventional
FCRC Chromosome 3p translocation Conventional
Hereditary paraganglioma SDHB Conventional
HPRC MET Papillary
HLRCC FH Papillary
Birt-Hogg-Dube Syndrome BHD Chromophobe / Oncocytoma
Adapted from Cohen HT, McGovern FJ. Renal-cell carcinoma.N Engl J Med. 2005; 353:2477-90


References

  1. 1.0 1.1 Cohen HT, McGovern FJ (2005). "Renal-cell carcinoma". N Engl J Med. 353 (23): 2477–90. doi:10.1056/NEJMra043172. PMID 16339096.


Template:WH Template:WS